4/A
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001387131-23-003381
Co-CEO & President bought 23,527,044 shares at $1.05 ($24,703,396)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-CEO & President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-08 | Purchase : show line 1 in the form | +16,778,415 | $1.05 | $17,617,336 | 24,573,798 | I |
| 2023-03-08 | Purchase : show line 2 in the form | +6,748,629 | $1.05 | $7,086,060 | 9,884,095 | I |
| Open-market purchases · 23,527,044 sh · avg $1.05 · $24,703,396 | ||||||
Loading xslF345X03/zangeneh-form4a_030823.xml…